These NOD.RipGAD2- Y line mice express a transgene containing a human B-cell autoantigen, GAD2, under control of a rat insulin promoter, Ins2.
Dr. Edward Leiter, The Jackson Laboratory
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
Transgenic mice are characterized by pancreatic beta cells that express a rat insulin promoter 7, Ins2, regulated transgene encoding a human B-cell autoantigen, GAD2. These mice are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. This NOD/Lt transgenic demonstrates a Y Chr. integration-site as only male progeny are transgenic. Expression of the transgene in the islets has been confirmed by RT-PCR and Western blot analysis. Southern analysis confirms 17 copies of the transgene are present, compared to the A-line that has 4-5 copies (Stock No. 5870). Elevated levels of GAD2 expression in transgenic B-cells do not influence non-fasting plasma levels of insulin and glucagon. At 50 weeks of age 55% of the transgenic males were diabetic, this is not significantly different from NOD/Lt male cohorts. Insulitis in 9 week old females is not significantly different between transgenics and controls.
This model provides a tool for studying at the role of autoantigens, specifically GAD2, in diabetes.
Glutamic acid decarboxylase 2, GAD2 (commonly referred to as GAD65) and located on Chr. 2, is highly expressed in human and rat beta cells, but little to no expression in mouse beta cells. Because GAD2 is a major candidate autoantigen in human T1D, a human GAD2 transgene under control of the Ins2 promoter was injected directly into NOD/Lt zygotes. In 2006, the T1DR received this transgenic strain at generation F?+33.
Expressed Gene | GAD2, glutamate decarboxylase 2, human |
---|---|
Site of Expression |
Allele Name | transgene insertion 1, Edward H Leiter |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | RIP7-hGAD65; TgN(RIP7hGAD65)Lt4 Y-line |
Gene Symbol and Name | Tg(Ins2-GAD2)1Lt, transgene insertion 1, Edward H Leiter |
Gene Synonym(s) | |
Promoter | Ins2, insulin 2, rat |
Expressed Gene | GAD2, glutamate decarboxylase 2, human |
Strain of Origin | NOD/ShiLt |
Chromosome | Y |
Molecular Note | The transgene comprises the cDNA sequence encoding human glutamic acid decarboxylase 2 under control of a modified rat insulin 2 promoter composed of 9.5 kb of genomic DNA from upstream of the transcription initiation site fused to the first intron of Ins2. Transmission from the founder male only to male progeny demonstrated integration into the Y chromosome. Densitrometric Southern blot analysis indicates presence of approximately 17 copies of the transgene. Expression in the pancreatic islets of transgenic mRNA has been demonstrated by reverse transcription followed by PCR (RT-PCR), and of GAD2 protein by western blot analysis. |
A footpad injection of Complete Freund s Adjuvant (CFA) administered once at weaning will delay diabetes onset, thus extending the lifespan of breeders. Use of Complete Freund s Adjuvant in NOD mice can be found in Current Protocols in Immunology page 15.9.19, Reproduction.
When using the NOD.RipGAD2- Y line mouse strain in a publication, please cite the originating article(s) and include JAX stock #003074 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
X linked - Carrier Females and non-carrier Males for Tg(Ins2-GAD2)1Lt, 1 pair minimum |
Frozen Mouse Embryo | NOD/ShiLt-Tg(Ins2-GAD2)1Lt/LtJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD/ShiLt-Tg(Ins2-GAD2)1Lt/LtJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD/ShiLt-Tg(Ins2-GAD2)1Lt/LtJ Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | NOD/ShiLt-Tg(Ins2-GAD2)1Lt/LtJ Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.